Geneos Wealth Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-227
Closed -$2K 2034
2022
Q2
$2K Hold
227
﹤0.01% 2358
2022
Q1
$7K Hold
227
﹤0.01% 2199
2021
Q4
$11K Hold
227
﹤0.01% 2125
2021
Q3
$10K Hold
227
﹤0.01% 2204
2021
Q2
$7K Buy
227
+126
+125% +$2.57K ﹤0.01% 2317
2021
Q1
$1K Hold
101
﹤0.01% 2984
2020
Q4
$2K Hold
101
﹤0.01% 2672
2020
Q3
$1K Buy
+101
New +$799 ﹤0.01% 2486

Other funds holding ASPN

Geneos Wealth Management's ASPN Position: Q3 2022 in Review

Geneos Wealth Management sold out of Aspen Aerogels (ASPN) in Q3 2022, closing a stake of 227 shares — an estimated $2K sold.

Geneos Wealth Management first reported a position in ASPN in Q3 2020 and held it in 8 quarters. The position peaked at $11K in Q4 2021. 139 funds tracked by Wall St. Rank hold ASPN as of Q3 2022.

  • Geneos Wealth Management reported no remaining Aspen Aerogels position as of Q3 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 227 Aspen Aerogels shares in Q3 2022, an estimated $2K.
  • Geneos Wealth Management first reported a position in Aspen Aerogels in Q3 2020 and held it in 8 quarters.
  • Geneos Wealth Management's Aspen Aerogels position peaked at $11K in Q4 2021.
  • 139 funds tracked by Wall St. Rank held Aspen Aerogels as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.